Clinical and Immunological Features of Severe and Moderate Coronavirus Disease 2019

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2020 Mar 29

PMID 32217835

Citations 2817

Authors

Guang Chen

Di Wu

Wei Guo

Yong Cao

Da Huang

Hongwu Wang

Tao Wang

Xiaoyun Zhang

Huilong Chen

Haijing Yu

Xiaoping Zhang

Minxia Zhang

Shiji Wu

Jianxin Song

Tao Chen

Meifang Han

Shusheng Li

Xiaoping Luo

Jianping Zhao

Qin Ning

Affiliations

Soon will be listed here.

Abstract

BACKGROUNDSince December 2019, an outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, and is now becoming a global threat. We aimed to delineate and compare the immunological features of severe and moderate COVID-19.METHODSIn this retrospective study, the clinical and immunological characteristics of 21 patients (17 male and 4 female) with COVID-19 were analyzed. These patients were classified as severe (11 cases) and moderate (10 cases) according to the guidelines released by the National Health Commission of China.RESULTSThe median age of severe and moderate cases was 61.0 and 52.0 years, respectively. Common clinical manifestations included fever, cough, and fatigue. Compared with moderate cases, severe cases more frequently had dyspnea, lymphopenia, and hypoalbuminemia, with higher levels of alanine aminotransferase, lactate dehydrogenase, C-reactive protein, ferritin, and D-dimer as well as markedly higher levels of IL-2R, IL-6, IL-10, and TNF-α. Absolute numbers of T lymphocytes, CD4+ T cells, and CD8+ T cells decreased in nearly all the patients, and were markedly lower in severe cases (294.0, 177.5, and 89.0 × 106/L, respectively) than moderate cases (640.5, 381.5, and 254.0 × 106/L, respectively). The expression of IFN-γ by CD4+ T cells tended to be lower in severe cases (14.1%) than in moderate cases (22.8%).CONCLUSIONThe SARS-CoV-2 infection may affect primarily T lymphocytes, particularly CD4+ and CD8+ T cells, resulting in a decrease in numbers as well as IFN-γ production by CD4+ T cells. These potential immunological markers may be of importance because of their correlation with disease severity in COVID-19.TRIAL REGISTRATIONThis is a retrospective observational study without a trial registration number.FUNDINGThis work is funded by grants from Tongji Hospital for the Pilot Scheme Project, and partly supported by the Chinese National Thirteenth Five Years Project in Science and Technology for Infectious Disease (2017ZX10202201).

Citing Articles

Role of innate immunity in SARS-CoV-2 infection.

Wang Z, Cheng F, Xu Y, Li X, Meng S Biosaf Health. 2025; 5(5):280-288.

PMID: 40078906 PMC: 11894970. DOI: 10.1016/j.bsheal.2023.08.005.

The Impact of SARS-CoV-2 Infection on Glucose Homeostasis in Hospitalized Patients with Pulmonary Impairment.

Parliteanu O, Balteanu M, Zaharia D, Constantinescu T, Cristea A, Dumitrache-Rujinscki S Diagnostics (Basel). 2025; 15(5).

PMID: 40075801 PMC: 11898410. DOI: 10.3390/diagnostics15050554.

Single-cell immune aging clocks reveal inter-individual heterogeneity during infection and vaccination.

Li W, Zhang Z, Kumar S, Botey-Bataller J, Zoodsma M, Ehsani A Nat Aging. 2025; .

PMID: 40044970 DOI: 10.1038/s43587-025-00819-z.

The predictive value of the LDH-albumin ratio on poor clinical course and mortality in COVID-19 patients: A single-center study.

Kaya H, Argun Baris S, Gultepe B, Basyigit I, Boyaci H Medicine (Baltimore). 2025; 104(9):e41660.

PMID: 40020123 PMC: 11875623. DOI: 10.1097/MD.0000000000041660.

Deep learning enhances the prediction of HLA class I-presented CD8 T cell epitopes in foreign pathogens.

Wohlwend J, Nathan A, Shalon N, Crain C, Tano-Menka R, Goldberg B Nat Mach Intell. 2025; 7(2):232-243.

PMID: 40008296 PMC: 11847706. DOI: 10.1038/s42256-024-00971-y.

References

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

Yang M, Li C, Li K, Hon K, Ng M, Chan P . Hematological findings in SARS patients and possible mechanisms (review). Int J Mol Med. 2004; 14(2):311-5. View

Zaki A, van Boheemen S, Bestebroer T, Osterhaus A, Fouchier R . Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012; 367(19):1814-20. DOI: 10.1056/NEJMoa1211721. View

Gralinski L, Menachery V . Return of the Coronavirus: 2019-nCoV. Viruses. 2020; 12(2). PMC: 7077245. DOI: 10.3390/v12020135. View

He Z, Zhao C, Dong Q, Zhuang H, Song S, Peng G . Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. Int J Infect Dis. 2005; 9(6):323-30. PMC: 7110876. DOI: 10.1016/j.ijid.2004.07.014. View

Zhao J, Li K, Wohlford-Lenane C, Agnihothram S, Fett C, Zhao J . Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci U S A. 2014; 111(13):4970-5. PMC: 3977243. DOI: 10.1073/pnas.1323279111. View

Arabi Y, Arifi A, Balkhy H, Najm H, Aldawood A, Ghabashi A . Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014; 160(6):389-97. DOI: 10.7326/M13-2486. View

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

Chu H, Zhou J, Wong B, Li C, Chan J, Cheng Z . Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways. J Infect Dis. 2015; 213(6):904-14. PMC: 7107330. DOI: 10.1093/infdis/jiv380. View

10.

Chen J, Lau Y, Lamirande E, Paddock C, Bartlett J, Zaki S . Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J Virol. 2009; 84(3):1289-301. PMC: 2812346. DOI: 10.1128/JVI.01281-09. View

11.

Xu X, Gao X . Immunological responses against SARS-coronavirus infection in humans. Cell Mol Immunol. 2005; 1(2):119-22. View

12.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-513. PMC: 7135076. DOI: 10.1016/S0140-6736(20)30211-7. View

13.

Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

14.

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

15.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

16.

Ying T, Li W, Dimitrov D . Discovery of T-Cell Infection and Apoptosis by Middle East Respiratory Syndrome Coronavirus. J Infect Dis. 2015; 213(6):877-9. PMC: 4760413. DOI: 10.1093/infdis/jiv381. View

17.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

18.

Channappanavar R, Fehr A, Vijay R, Mack M, Zhao J, Meyerholz D . Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe. 2016; 19(2):181-93. PMC: 4752723. DOI: 10.1016/j.chom.2016.01.007. View

19.

Zhao J, Zhou G, Sun Y, Wang S, Yang J, Meng E . [Clinical pathology and pathogenesis of severe acute respiratory syndrome]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004; 17(3):217-21. View

20.

Frasca L, Piazza C, Piccolella E . CD4+ T cells orchestrate both amplification and deletion of CD8+ T cells. Crit Rev Immunol. 1998; 18(6):569-94. DOI: 10.1615/critrevimmunol.v18.i6.50. View